As secretory proteins, serum TFF3 levels have also been proposed as a screening marker for various cancers, including breast [93], gastric [94], prostate [95], pancreatic [96], and lung [97], and cholangiocarcinoma [98]. This evidence concerns the gene TFF3 and cholangiocarcinoma.